Top news of the week: 03.11.2020.
#COVID19 #CRISPR #Nobel #womeninscience #genetics #NBTInTheirWords #womeninSTEM #womeninacademia
Companies And Industries
The Dish’s Weekly Biotechnology News Wrap Up – October 30, 2020
*|RSSFEED:DATE|* Incase you missed it. We summarized the week's top biotechnology stories.
RT @KHefferon: Clinical Research Program and COVID-19 Collaboration Launched in Nigeria https://t.co/VkhjKvwvbx via @GENbio
OpenClinical Research Program and COVID-19 Collaboration Launched in Nigeria
54gene has launched a clinical research program in Nigeria to discover, develop, and commercialize new therapeutic and diagnostic products.
Biden’s policies could spell trouble for biotech — but industry CEOs are backing him anyway #NBTInTheirWords via @statnews https://t.co/tPfMndpDeg https://t.co/405LdGVy5p
OpenBiden’s policies could spell trouble for biotech — but industry CEOs are backing him anyway
Biden could be a potential disaster for the biotech industry. But its CEOs are supporting him more vocally than ever before.
We are pleased to announce that LabTAG by GA International has just become one of our sponsors! Learn more: https://t.co/qLywcxDdzU @labtagofficial https://t.co/6QzMQ1MJgB
OpenLabTAG by GA International
LabTAG, a division of GA International, is a manufacturer of specialty labels and a provider of label printing equipment and services. For over 20 years we have been serving the …
AB2 Bio and WuXi Biologics agreed to collaborate to set up and accelerate commercial-scale manufacturing on Orphan Drug Manufacture.
Read now: https://t.co/NFPl9loy46 https://t.co/Z8j2QV5C66
OpenAB2 Bio and WuXi Biologics Collaborate on Orphan Drug Manufacture
WuXi will undertake commercial scale manufacturing to support U.S. market launch of IL-18 binding protein currently in pivotal Phase III testing.
RT @GENbio: Join us Friday, November 20 for part 4 of our #womeninscience webinar series. #CRISPR pioneer and 2020 #Nobel Laureate Jennifer Doudna will join us with some special guests for conversation and celebration. Register now: https://t.co/xOPbxu5t5i #womeninSTEM #womeninacademia https://t.co/Tmzf8Xyhp2
OpenWomen in Science Webinar Registration
The Rosalind Franklin Society presents the Women in Science Webinar with special guest Nobel Prize Laureate Jennifer Doudna CRISPR pioneer Jennifer Doudna, PhD (University of California, ...
French pharma @sanofi is to acquire @KiadisPharma, a biotech specialising in therapies based around ‘off the shelf’ natural killer (NK) cells, for 308 million euros ($353 million) https://t.co/tLEWcYrIVv
OpenSanofi to acquire Kiadis and NK cell tech for $353 million
Sanofi is to acquire Kiadis, a biotech specialising in therapies based around ‘off the shelf’ natural killer (NK) cells, for 308 million euros ($353 million).
RT @megtirrell: What do drug companies owe the patients who participate in their clinical trials?
A great read, and a question relevant also to the #covid19 vaccine trials. https://t.co/bkOLeOVBna
OpenThe Stressful Conclusion of a Clinical Trial
Does a pharmaceutical company have a moral obligation to acknowledge my participation with an ongoing supply of the product that I helped test?